Free tool
Diagnostics stocks
We cover 27 companies grouped under the Diagnostics theme. The median market value in the group is $1.02B. Across the group, the median move over the past trading day is +2.60%. 67% of the 27 with a 200-day average trade above it. Price change over the past year runs from −45.7% to +170.8% across the middle 80 percent of the group, with a median of +13.2%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
27 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $43.65 | +6.26% | −3.41% | −10.74% |
| CAI | Caris Life Sciences, Inc. | $28.01 | +79.21% | +3.82% | −27.21% |
| BLLN | BillionToOne, Inc. | $100.08 | −21.80% | +12.08% | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $26.25 | +16.46% | +64.99% | +107.18% |
| GRAL | GRAIL, Inc. | $82.54 | +23.62% | −7.12% | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $44.04 | −20.81% | +3.89% | +49.04% |
| CDNA | CareDx, Inc. | $50.80 | +39.71% | +165.41% | +298.43% |
| WGS | GeneDx Holdings Corp. | $87.41 | +44.38% | −33.93% | −28.28% |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% |
| NEO | NeoGenomics, Inc. | $16.79 | +27.78% | +42.77% | +160.31% |
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| DASA3.SA | Diagnósticos da América S.A. | 2.62 BRL | −8.07% | −41.52% | +111.29% |
| FLGT | Fulgent Genetics, Inc. | $19.95 | +1.89% | −22.04% | −7.34% |
| NNNN | Anbio Biotechnology | $7.83 | −23.08% | −73.44% | −84.06% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| BDSX | Biodesix, Inc. | $28.08 | +26.35% | +334.60% | +186.48% |
| MYGN | Myriad Genetics, Inc. | $3.19 | −41.47% | −48.05% | −45.84% |
| OSUR | OraSure Technologies, Inc. | $3.78 | −4.55% | +58.82% | +20.38% |
| LUCD | Lucid Diagnostics Inc. | $1.01 | +11.85% | −9.82% | −12.93% |
| XGN | Exagen Inc. | $7.60 | +72.73% | +25.83% | −22.84% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.44 | −5.53% | −37.99% | +78.31% |
| PCSC | Perceptive Capital Solutions Corp | $11.95 | +0.67% | −8.08% | +13.16% |
| QUCY | Quantum Cyber N.V. | $1.36 | +23.64% | +17.24% | −20.93% |
| BNR | Burning Rock Biotech Limited | $9.80 | +4.26% | −50.20% | +13.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.